Covaxin Trials In Children To Begin In 10-12 Days

The Phase II/III clinical trial of Covaxin, indigenous COVID-19 vaccine, in the 2-18-year-olds will begin in the next 10-12 days and has been approved by the Drugs Controller General Of India, senior...

from NDTV News - Special https://ift.tt/3fr4IDM
via IFTTT